Challenges in the Monitoring of Therapeutic Plasma Exchange during Acute Heparin-Induced Thrombocytopenia in Adults under ECMO
Case series published in TH open : companion journal to thrombosis and haemostasis (2024)
Resumen
Therapeutic plasma exchange (TPE) has been proposed to remove heparin-induced thrombocytopenia (HIT) antibodies before planned thoracic surgery in patients with acute HIT and to allow brief re-exposure to heparin during surgery. In patients on extracorporeal membrane oxygenation (ECMO), simultaneous administration of TPE and alternative nonheparin anticoagulant therapies is challenging. We report 2 patients on ECMO with acute HIT who underwent repeated TPE to enable cardiothoracic surgery with the use of heparin. In both cases, serial monitoring of HIT antibody titer and heparin-induced platelet activation assay (HIPA) was performed. The effect of adding exogenous platelet factor 4 (PF4) in the HIPA was also tested. Negative anti-PF4/H IgG levels were achieved after 5 and 3 TPE sessions, respectively and patients could beneficiate from surgery with brief heparin re-exposure without any thrombotic complication. Negative HIPA results were obtained before negative anti-PF4/H IgG in one patient but remained positive in the other despite very low antibody titers. The addition of PF4 in HIPA led to more contrasted results for the two patients. Serial HIT screening including immunological and functional assays is necessary to closely monitor TPE in acute HIT patients on ECMO who require surgery. The addition of PF4 in HIPA could help detect clinically relevant platelet-activating antibodies and guide re-exposure to heparin.
Resumen tomado de PubMed (NCBI) para el registro citado, en el idioma original. La versión de referencia es la de la publicación original.
El resumen se deja sin traducir para conservar la redacción original de los autores.
Síntesis
Two ECMO patients with acute heparin-induced thrombocytopenia underwent repeated therapeutic plasma exchange until anti-PF4/heparin IgG turned negative (after 5 and 3 sessions), enabling cardiothoracic surgery with brief heparin re-exposure and no thrombotic complications.
Por qué esto importa para la hirudoterapia
Esta serie de casos de dos pacientes describe el uso de plasmaféresis terapéutica repetida (TPE) para eliminar los anticuerpos contra heparina/PF4 en adultos en ECMO con trombocitopenia inducida por heparina (HIT) aguda, con el fin de permitir la breve reexposición a heparina para la cirugía torácica y cardíaca; según el resumen, ambos pacientes alcanzaron anti-PF4/heparina IgG negativos después de varias sesiones de TPE y se sometieron a cirugía sin complicaciones trombóticas, recomendándose un seguimiento inmunológico y funcional (HIPA) seriado, incluyendo PF4 exógeno añadido, para guiar la reexposición. La relevancia para la hirudoterapia es contextual: ilustra la dificultad para manejar la heparina una vez que aparecen los anticuerpos de HIT, el escenario en el que se consideran inhibidores directos de la trombina no heparínicos como la hirudina. Advertencia: con solo dos pacientes y sin grupo de comparación, esto es evidencia preliminar y descriptiva, y se refiere a heparina y TPE y no a ningún agente derivado de sanguijuelas.
Citación
Challenges in the Monitoring of Therapeutic Plasma Exchange during Acute Heparin-Induced Thrombocytopenia in Adults under ECMO.
Gendron et al. · TH open : companion journal to thrombosis and haemostasis, 2024
Contexto clínico relacionado
Explore cómo esta investigación se conecta con la práctica clínica
Investigación relacionada
Más estudios revisados por pares en la categoría «Ensayos clínicos».
- Leech Therapy for Knee Osteoarthritis — The Landmark RCT — Michalsen et al. (2003)
- Leech-Assisted Flap Salvage — Systematic Review of 277 Cases — Whitaker et al. (2012)
- Effects of hirudotherapy on liver functions, lipid profile, and insulin sensitivity in rats with metabolic syndrome — Bilden A et al. (2026)
- Efficacy and Safety of Hirudotherapy for Improving Sperm Quality Parameters in Male Infertility: A Randomized Controlled Trial — Abtahi-Forooshani M et al. (2026)
- Reverse Sural Flap Venous Congestion Successfully Managed With Enoxaparin in a Male Patient With a Traumatic Foot Crush Injury: A Case Report — Velasco-Bustamante J et al. (2026)
- Investigación de los efectos terapéuticos del tratamiento con sanguijuelas medicinales sobre la lesión por isquemia-reperfusión de la extremidad inferior — Ünal K et al. (2026)
- Efficacy of Medicinal Leech Therapy in Diverse Clinical Applications: A Comprehensive Study from Azerbaijan — Farzali S et al. (2025)
- HIRUDOTHERAPY IN RECONSTRUCTIVE SURGERY: CASE-REPORTS AND REVIEW — Heinz P et al. (2020)
- Hirudoterapia en la cicatrización de heridas — Nair H et al. (2022)
- Improvement of patient care through hirudotherapy and the management of leeches from their reception to their disposal in France — Vaesken C et al. (2023)
Añadido a la biblioteca ASH: 28 de mayo de 2026 · Última actualización del sitio: 18 de junio de 2026